FDA Issues New Heart Attack, Stroke Risk Warnings for NSAIDs
نویسندگان
چکیده
منابع مشابه
The FDA and new safety warnings.
Comment. The majority of primary health care providers agree that their patients should reduce sodium intake; report providing specific advice in line with recommended strategies; and counsel patients with prehypertension, hypertension, or chronic kidney disease to consume less salt. In contrast to 2010 dietary guidelines, a minority of health care providers report counseling patients with diab...
متن کاملFDA approves new drug to reduce risk of stroke.
Anew drug to reduce the risk of stroke has received approval from the US Food and Drug Administration. The new drug combines aspirin and dipyridamole into one pill to reduce the risk of stroke for patients who have already had transient ischemic attacks or ischemic strokes caused by blood clots in the brain. Approximately 500 000 people in the United States have strokes each year, and 150 000 d...
متن کاملCalcium supplements can increase risk of heart attack and stroke
“We conclude that the moderate effect of supplemental calcium and vitamin D on the risk of fractures is not large enough to outweigh the potential increased risk of cardiovascular disease, specifically in women who are at a low risk of bone fracture,” said Gunhild Hagen, a PhD candidate at the Department of Public Heath and General Practice who was first author of an article on the study recent...
متن کاملNonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke.
BACKGROUND AND PURPOSE There is limited information regarding the cerebrovascular safety of cyclooxygenase 2 inhibitors (coxibs) and noncoxib nonsteroidal antiinflammatory drugs (NSAIDs). We determined whether specific NSAIDs, including coxibs, are associated with risk of stroke. METHODS Retrospective cohort study among Tennessee Medicaid enrollees aged 50 to 84 years between January 1, 1999 ...
متن کاملHeart attack or rhabdomyolysis?
Statins are commonly used drugs in the treatment of hyperlipidemia (HL), despite some undesirable side effects. These range from mild symptoms such as myopathy, muscle weakness and myalgia to severe muscle weakness associated with chronic myopathy and acute renal failure (ARF) as a result of rhabdomyolysis. The most serious and deadly side effect of statins is rhabdomyolysis. The case presente...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Caring for the Ages
سال: 2015
ISSN: 1526-4114
DOI: 10.1016/j.carage.2015.08.017